Spots Global Cancer Trial Database for Study on TIL for the Treatment of Brain Glioma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study on TIL for the Treatment of Brain Glioma
Official Title: A Clinical Safety and Efficacy Study on TIL for the Treatment of Glioma
Study ID: NCT04943913
Conditions
Interventions
Study Description
Brief Summary: This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with malignant glioma . Autologous TILs are expanded from tumor resections and infused i.v. into the patient after NMA lymphodepletion treatment with hydroxychloroquine(600mg,single-dose) and cyclophosphamide.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact Details
Name: Qing Lan
Affiliation: Second Affiliated Hospital of Soochow University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
